Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Marie, Parish"'
Autor:
Ronald E, Cox, Marie, Parish, Carolyn, Oxencis, Edward, Mckenna, Bicky, Thapa, Sakti, Chakrabarti
Publikováno v:
World Journal of Clinical Oncology. 13:599-608
There are currently three coronavirus disease 2019 (COVID-19) vaccines approved by the United States Food and Drug Administration to prevent coronavirus infection. However, robust data are unavailable on the adverse events of the vaccines in patients
Publikováno v:
Journal of Clinical Oncology. 41:89-89
89 Background: Enterocolitis is a potentially fatal toxicity of CAPE. The safety of infusional 5-FU-based regimens in patients developing severe enterocolitis with CAPE is not well established in the literature. Methods: After institutional review bo
Autor:
Sakti Chakrabarti, Marie Parish, Carrie Peterson, Kirk A. Ludwig, Deepika Sriram, Antony Ruggeri, Sameer Tolay, Jennifer Eva Selfridge, David L Bajor, Amr Mohamed, Amit Mahipal, Aditya V. Shreenivas
Publikováno v:
Journal of Clinical Oncology. 41:105-105
105 Background: Patients with potentially resectable dMMR/MSI-H colon cancer (CC) often receive neoadjuvant immunotherapy (IO) if co-morbid conditions or the extent of disease preclude upfront surgery. We investigated the outcome of such patients tre
Autor:
Aditya Shreenivas, Edward J. Mckenna, Marie Parish, Bicky Thapa, Sakti Chakrabarti, Ronald E Cox
Publikováno v:
International Journal of Cancer Care and Delivery. 1
Autor:
Marie Parish, Ronald Cox, Bicky Thapa, Edward McKenna, Carolyn Oxencis, Aditya V. Shreenivas, Mandana Kamgar, Ben George, James P. Thomas, Sakti Chakrabarti
Publikováno v:
Journal of Clinical Oncology. 40:656-656
656 Background: Non-neutropenic enterocolitis (NNEC), a potentially fatal toxicity of capecitabine (CAPE), is under-reported in the literature. An institutional review was performed to determine the incidence, clinical course, and outcome of patients
Autor:
Edward McKenna, Carolyn Oxencis, Marie Parish, Daniel Eastwood, James Miller, Aditya V. Shreenivas, Mandana Kamgar, Ben George, William A. Hall, Beth Erickson, Kirk A. Ludwig, Aniko Szabo, James P. Thomas, Sakti Chakrabarti
Publikováno v:
Journal of Clinical Oncology. 40:44-44
44 Background: Despite an alarming rise in incidence, data on survival outcome and treatment response of young-onset (age < 50 years) locally advanced rectal cancer (YO-LARC) patients receiving total neoadjuvant therapy (TNT) are sparse. We retrospec